Similarities and differences between IL-2 and IL-15 effects on NK cells have been extensively reviewed elsewhere, and IL-15 might be the preferable cytokine for cancer therapy as it inhibits activation-induced cell death and it is considered safe (83–85). The gene discussed is IL15; the disease is cancer.